Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

NCT03306680

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • BC Cancer -Vancouver Island Vancouver, British Columbia, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

NCT02788461

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kingston General Hospital Kingston, Ontario, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Stronach Regional Cancer Centre at Southlake Regional Health Centre Newmarket, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

NCT03485378

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Alberta Health Services, Cross Cancer Institude Edmonton, Alberta, Canada
  • London Regional Cancer Program of the Lawson Health Research Institute London, Ontario, Canada
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • UHN Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

NCT04547504

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU AMIENS - Hôpital Sud Amiens, France
  • Chu Angers Angers, France
  • CHRU de Brest Brest, France
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)

NCT05722015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023) Phoenix, Arizona, United States
  • Clermont Oncology Center ( Site 0018) Clermont, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0010) Orange City, Florida, United States
  • University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0022) Chicago, Illinois, United States
View all 110 locations
View Trial Details

Related conditions